Episode #994
#995 India’s Growth Story and the Cost of Regulatory Cholesterol
India has built one of the world’s largest pharmaceutical industries. But scale alone is no longer enough. In this episode of The Core Report: Weekend Edition , Govindraj Ethiraj speaks with Manish Sabharwal, Chairman and Co-founder of TeamLease Services, about what India’s pharma success can teach the rest of the economy and why the country still struggles to turn entrepreneurial ambition into globally competitive companies. Drawing from Made in India , the book on Lupin founder D.B. Gupta, Sabharwal discusses how Indian pharma moved from a licence-era industry to a global manufacturing force, why the next challenge is shifting from volume to value, and what is still holding back innovation, manufacturing and productivity. The conversation also explores India’s unfinished deregulation agenda, why capital is no longer the biggest constraint for businesses, the need for stronger governance and professional management, and why Indian companies may have to choose focus over excessive diversification. Sabharwal also makes the case that India’s larger economic challenge is not simply creating more jobs, but creating more productive, better-paying jobs and moving millions of workers from low-productivity agriculture into higher-value sectors. The episode is ultimately about a bigger question: What will it take for India to build more companies that can scale, innovate and compete globally? Register for our event “Don’t Miss a Beat: The Hidden Risks to Indians” For more of our coverage check out thecore.in Follow us on: Twitter | Instagram | Linkedin | Youtube
